Page 90 - journal-7-1-Full

¯Ú «“√ “√°“√·æ∑¬å·ºπ‰∑¬·≈–°“√·æ∑¬å∑“߇≈◊Õ° ªï∑’Ë ˜©∫—∫∑’Ë Ò ¡°√“§¡-‡¡…“¬π ÚııÚ

al. Minimal persistent inflammation is present at mucosal level in with rhinitis and asthma--a placebo controlled study. Ann Allergy Asthma
patients with asymptomatic rhinitis and mite allergy. J Allergy Clin Immunol 1999;82:485-90.
Immunol 1995;96:971-9. ÛÙ. Passalacqua G, Albano M, Fregonese L, Riccio A, Pronzato C, Mela
Ú˜. Walden SM, Proud D, Lichtenstein LM, Kagey-Sobotka A, Naclerio GS, et al. Randomized controlled trial of local allergoid immunotherapy
RM. Antigen-provoked increase in histamine reactivity: observations on allergic inflammation in mite-induced rhinoconjunctivitis. Lancet
on mechanisms. Am Rev Respir Dis 1991;144:642-8. 1998;351:629-32.
Ú¯. Klementsson H, Andersson M, Baumgarten CR, Venge P, Pipkorn U. Ûı. Ebner C, Siemann U, Bohle B, Willheim M, Wiedermann U, Schenk
Changes in non-specific nasal reactivity and eosinophil influx and S, et al. Immunological changes during specific immunotherapy of
activation after allergen challenge. Clin Exp Allergy 1990;20:539-47. grass pollen allergy: reduced lymphoproliferative responses to allergen
Ú˘. Sibbald B, Strachen DP. Epidemiology of rhinitis. In: Busse WW, and shift from TH2 to THl in T-cell clones specific for Phl p 1, a major
Holgate ST, editors. Asthma and Rhinitis. Boston: Blackwell Scientific grass pollen allergen. Clin Exp Allergy 1997;27:1007-15.
Publications; 1995. p. 32-43. Ûˆ. Meissner N, Kochs S, Coutelle J, Kussebi F, Baumgarten C, Lowenstein
Û. ©«’«√√≥ ∫ÿππ“§, ª√‘¡≥±å °“≠®π—…∞‘μ‘, ∫ÿ≠‡®◊Õ ∏√≥‘π∑√å. The H, et al. Modified T-cell activation pattern during specific immunotherapy
incidence of sinus involvement in allergic rhinitis in Thai patients. In: (SIT) in cat-allergic patients. Clin Exp Allergy 1999;29:618-25.
Takahashi R, editor. Proceeding international symposium of infection Û˜. Durham SR, Ying S, Varney VA, Jacobson MR, Sudderick RM, Mackay
and allergy of the nose and paranasal sinuses. Tokyo: Scimed IS, et al. Grass pollen immunotherapy inhibits allergen-induced
Publications; 1977. p. 273-7. infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa
ÛÒ. Jen A, Baroody FM, deTineo M, Haney L, Blair C, Naclerio RM. As and increases the number of cells expressing messenger RNA for
needed use of fluticasone propionate nasal spray reduces symptoms interferon-gamma. J Allergy Clin Immunol 1996;97:1356-65.
of seasonal allergic rhinitis. J Allergy Clin Immunol 2000;105:732-8. Û¯. Klimek L, Dormann D, Jarman ER, Cromwell O, Riechelmann H,
ÛÚ. Andri L, Senna G, Betteli C, Givanni S, Andri G, Falagiani P. Local Reske-Kunz AB. Short-term preseasonal birch pollen allergoid
nasal immunotherapy for Dermatophagoides-induced rhinitis: efficacy immunotherapy influences symptoms, specific nasal provocation and
of a powder extract. J Allergy Clin Immunol 1993;91:987-96. cytokine levels in nasal secretions, but not peripheral T-cell responses,
ÛÛ. Mungan D, Misirligil Z, Gurbuz L. Comparison of the efficacy of in patients with allergic rhinitis. Clin Exp Allergy 1999; 29:1326-35.
subcutaneous and sublingual immunotherapy in mite-sensitive patients